PEN (STOCKS)
Penumbra, Inc.
$338.260000
-0.710000 (-0.21%)
Prev close: $338.970000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Adam Elsesser
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13,265.92M
- Employees
- 4,500
- P/E (TTM)
- 80.84
- P/B (TTM)
- 9.75
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.33B |
| Benefits Costs and Expenses | $1.15B |
| Cost Of Revenue | $442.77M |
| Costs And Expenses | $1.15B |
| Gross Profit | $891.03M |
| Nonoperating Income/Loss | $13.04M |
| Operating Expenses | $718.24M |
| Selling, General, and Administrative Expenses | $630.26M |
| Other Operating Expenses | $87.98M |
| Operating Income/Loss | $172.79M |
| Income/Loss From Continuing Operations After Tax | $164.03M |
| Income/Loss From Continuing Operations Before Tax | $185.83M |
| Income Tax Expense/Benefit | $21.81M |
| Net Income/Loss | $164.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $164.03M |
| Net Income/Loss Available To Common Stockholders, Basic | $164.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $4.23 |
| Diluted Earnings Per Share | $4.19 |
| Basic Average Shares | 38,753,973 |
| Diluted Average Shares | 39,811,908 |
| Assets | $1.74B |
| Current Assets | $1.14B |
| Inventory | $432.37M |
| Other Current Assets | $709.16M |
| Noncurrent Assets | $602.85M |
| Fixed Assets | $97.73M |
| Intangible Assets | $6.37M |
| Other Non-current Assets | $498.75M |
| Liabilities | $385.67M |
| Current Liabilities | $169.60M |
| Accounts Payable | $29.82M |
| Wages | $79.40M |
| Other Current Liabilities | $60.39M |
| Noncurrent Liabilities | $216.07M |
| Equity | $1.36B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.36B |
| Liabilities And Equity | $1.74B |
| Net Cash Flow From Operating Activities | $203.29M |
| Net Cash Flow From Operating Activities, Continuing | $203.29M |
| Net Cash Flow From Investing Activities | -$189.90M |
| Net Cash Flow From Investing Activities, Continuing | -$189.90M |
| Net Cash Flow From Financing Activities | $27.54M |
| Net Cash Flow From Financing Activities, Continuing | $27.54M |
| Exchange Gains/Losses | -$379.00K |
| Net Cash Flow | $40.55M |
| Net Cash Flow, Continuing | $40.93M |
| Comprehensive Income/Loss | $168.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $168.10M |
| Other Comprehensive Income/Loss | $4.08M |